Investor News
Accelus Announces FDA 510(k) Clearance of Remi Robotic Navigation System for Use with 2D Fluoroscopy-Based Imaging System
March 16, 2023
No Comments
Remi now cleared for use with most commonly used 2D and 3D imaging systems for spine surgery PALM BEACH GARDENS, Fla., March 16, 2023 (GLOBE
Accelus Announces FDA 510(k) Clearance for Remi Robotic Navigation System Software Update that Allows Image Acquisition with all Major 3D Imaging Systems
November 3, 2022
No Comments
PALM BEACH GARDENS, Fla., November 3, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive
Accelus Announces Global Expansion of its FlareHawk Interbody Fusion System
October 18, 2022
No Comments
Surgeons in 19 Countries Can Now Take Advantage of FlareHawk’s Minimal Insertion Profile, Multiplanar and Endplate-Conforming Expansion, and Maximum Graft Delivery PALM BEACH GARDENS, Fla.,
Accelus Investor Contact
Brian Johnston (Gilmartin Group)
ir@accelusinc.com
View the investor disclaimer below:
ir@accelusinc.com
View the investor disclaimer below:
